Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Verbio SE: Positive momentum for biofuels: Regulatory developments in the EU and the US
EQS-News: Verbio SE: Positive momentum for biofuels: Regulatory developments in the EU and the US
EQS-News: Verbio SE: Positive momentum for biofuels: Regulatory developments in the EU and the US
EQS-Adhoc: Verbio SE: Preliminary EBITDA for the 2024/2025 financial year below forecast; non-cash impairments in the 2024/2025 consolidated financial statements
EQS-Adhoc: Verbio SE: Preliminary EBITDA for the 2024/2025 financial year below forecast; non-cash impairments in the 2024/2025 consolidated financial statements
EQS-Adhoc: Verbio SE: Preliminary EBITDA for the 2024/2025 financial year below forecast; non-cash impairments in the 2024/2025 consolidated financial statements
EQS-News: Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
EQS-News: Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
EQS-News: Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
EQS-News: Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
EQS-News: Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
EQS-News: Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
EQS-News: Q2 2025: TeamViewer delivers 15 % Enterprise Revenue growth yoy and strong Adj. EBITDA margin of 44 %; reiterates FY guidance
EQS-News: Q2 2025: TeamViewer delivers 15 % Enterprise Revenue growth yoy and strong Adj. EBITDA margin of 44 %; reiterates FY guidance
EQS-News: Q2 2025: TeamViewer delivers 15 % Enterprise Revenue growth yoy and strong Adj. EBITDA margin of 44 %; reiterates FY guidance
EQS-News: Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
EQS-News: Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
EQS-News: Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
EQS-News: Eckert & Ziegler: Outstanding Training Quality Once Again Awarded
EQS-News: Eckert & Ziegler: Outstanding Training Quality Once Again Awarded
EQS-News: Eckert & Ziegler: Outstanding Training Quality Once Again Awarded
EQS-News: CVC successfully concludes public delisting offer for CompuGroup Medical
EQS-News: CVC successfully concludes public delisting offer for CompuGroup Medical
EQS-News: CVC successfully concludes public delisting offer for CompuGroup Medical
EQS-News: Delisting of CompuGroup Medical to become effective as of 24 June 2025
EQS-News: Delisting of CompuGroup Medical to become effective as of 24 June 2025
EQS-News: Delisting of CompuGroup Medical to become effective as of 24 June 2025
EQS-News: Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50
EQS-News: Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50
EQS-News: Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50
EQS-News: CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer
EQS-News: CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer
EQS-News: CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer
EQS-News: Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
EQS-News: Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
EQS-News: Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
EQS-News: Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum
EQS-News: Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum
EQS-News: Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum
EQS-News: 2025 Annual General Meeting of TeamViewer SE –  Shareholders elect new Supervisory Board member and approve all agenda items by a clear majority
EQS-News: 2025 Annual General Meeting of TeamViewer SE –  Shareholders elect new Supervisory Board member and approve all agenda items by a clear majority
EQS-News: 2025 Annual General Meeting of TeamViewer SE –  Shareholders elect new Supervisory Board member and approve all agenda items by a clear majority
EQS-News: Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time
EQS-News: Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time
EQS-News: Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time
Infineon to revolutionize power delivery architecture for future AI server racks with NVIDIA
Infineon to revolutionize power delivery architecture for future AI server racks with NVIDIA


Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is revolutionizing the power delivery architecture required for future AI data centers. In collaboration with NVIDIA, Infineon is developing the

Kontron Marks Two Years of Seamless Broadband Partnership with NT Fiber: https://upload.wikimedia.org/wikipedia/de/thumb/e/e9/Kontron_Logo.svg/1024px-Kontron_Logo.svg.png
Kontron Marks Two Years of Seamless Broadband Partnership with NT Fiber


Kontron, a global leader in broadband access solutions, proudly marks over two years of successful deployment with NT Fiber, a rapidly growing regional Internet Service Provider in Texas. As the

EQS-News: TeamViewer launches first Digital Workplace platform combining endpoint management, remote connectivity, AI, and DEX
EQS-News: TeamViewer launches first Digital Workplace platform combining endpoint management, remote connectivity, AI, and DEX
EQS-News: TeamViewer launches first Digital Workplace platform combining endpoint management, remote connectivity, AI, and DEX
EQS-News: Verbio SE: Verbio announces results for Q3 2024/25
EQS-News: Verbio SE: Verbio announces results for Q3 2024/25
EQS-News: Verbio SE: Verbio announces results for Q3 2024/25
EQS-News: Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast
EQS-News: Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast
EQS-News: Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast
EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: Q1 2025: TeamViewer Revenue up 7 % yoy, Enterprise ARR up 20 % yoy and Adj. EBITDA up 20 % yoy; FY guidance reiterated
EQS-News: Q1 2025: TeamViewer Revenue up 7 % yoy, Enterprise ARR up 20 % yoy and Adj. EBITDA up 20 % yoy; FY guidance reiterated
EQS-News: Q1 2025: TeamViewer Revenue up 7 % yoy, Enterprise ARR up 20 % yoy and Adj. EBITDA up 20 % yoy; FY guidance reiterated
EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm
EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm
EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm
EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer
EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer
EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer